<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CRISPR-Cas9 &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/crispr-cas9/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Thu, 22 Jan 2026 13:06:03 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>CRISPR-Cas9 &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Targeted Oncogene Editing Induces Tumor Remodelling and Immunity</title>
		<link>https://bioengineer.org/targeted-oncogene-editing-induces-tumor-remodelling-and-immunity/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 22 Jan 2026 13:05:51 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[CRISPR-Cas9]]></category>
		<category><![CDATA[Hedeflenmiş onkogen düzenlemesi]]></category>
		<category><![CDATA[immunogenic cell death]]></category>
		<category><![CDATA[immünojenik hücre ölümü]]></category>
		<category><![CDATA[Kanser immünoterapisi]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<category><![CDATA[targeted oncogene editing]]></category>
		<category><![CDATA[tumor remodeling]]></category>
		<category><![CDATA[tümör yeniden şekillendirmesi]]></category>
		<guid isPermaLink="false">https://bioengineer.org/targeted-oncogene-editing-induces-tumor-remodelling-and-immunity/</guid>

					<description><![CDATA[Recent advancements in cancer research have illuminated the path toward innovative therapeutic strategies aimed at precision medicine. A pivotal study published in the journal Molecular Cancer has caught the attention of scientists and medical professionals alike. The research, led by a team including Nieto-Sanchez, Martinez-Lage, and Puig-Serra, explores a groundbreaking technique in genome editing that [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319291</post-id>	</item>
		<item>
		<title>CRISPR Screens Identify Genes Driving Neuronal Differentiation</title>
		<link>https://bioengineer.org/crispr-screens-identify-genes-driving-neuronal-differentiation/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 14:09:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[CRISPR-Cas9]]></category>
		<category><![CDATA[Fonksiyonel Genomik]]></category>
		<category><![CDATA[Nörogelişimsel Bozukluklar]]></category>
		<category><![CDATA[Nöronal Farklılaşma]]></category>
		<category><![CDATA[PEDS1 Geni]]></category>
		<guid isPermaLink="false">https://bioengineer.org/crispr-screens-identify-genes-driving-neuronal-differentiation/</guid>

					<description><![CDATA[In a groundbreaking study published in Nature Neuroscience, researchers have unveiled new insights into the genetic underpinnings of neurodevelopmental disorders (NDDs) by utilizing cutting-edge CRISPR-Cas9 technology. Neurodevelopmental disorders, which encompass a wide spectrum of conditions arising from disrupted brain development, remain largely enigmatic in terms of their molecular and cellular bases. This study leverages genome-wide [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313717</post-id>	</item>
		<item>
		<title>Transcription Factors Guide Leaf Margin Growth in Roses</title>
		<link>https://bioengineer.org/transcription-factors-guide-leaf-margin-growth-in-roses/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 05 Jan 2026 04:30:33 +0000</pubDate>
				<category><![CDATA[Biology]]></category>
		<category><![CDATA[CRISPR-Cas9]]></category>
		<category><![CDATA[Leaf margin development]]></category>
		<category><![CDATA[Plant morphology]]></category>
		<category><![CDATA[Rosa persica]]></category>
		<category><![CDATA[RpNACs transcription factors]]></category>
		<guid isPermaLink="false">https://bioengineer.org/transcription-factors-guide-leaf-margin-growth-in-roses/</guid>

					<description><![CDATA[In the realm of plant biology, the intricate mechanisms that govern the development of plant structures are of paramount interest. Recent research has shed light on the role of specific transcription factors in the leaf margin development of the ornamental species, Rosa persica, particularly focusing on the RpNACs family. This study, led by a team [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">313626</post-id>	</item>
		<item>
		<title>Gene Editing Breakthroughs for Collagen Disorders Ahead</title>
		<link>https://bioengineer.org/gene-editing-breakthroughs-for-collagen-disorders-ahead/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Sun, 16 Nov 2025 23:36:21 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Collagen disorders]]></category>
		<category><![CDATA[CRISPR-Cas9]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genetic mutations]]></category>
		<category><![CDATA[Precision Medicine]]></category>
		<guid isPermaLink="false">https://bioengineer.org/gene-editing-breakthroughs-for-collagen-disorders-ahead/</guid>

					<description><![CDATA[In a groundbreaking study published in Gene Therapy, researchers have illuminated the possibilities of gene editing for collagen disorders, highlighting significant advancements and future perspectives in the field. Collagen, the most abundant protein in the human body, plays a critical role in maintaining the structural integrity of various tissues, including skin, bones, and connective tissues. [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">297633</post-id>	</item>
		<item>
		<title>Progress in Collagen Disorder Research and Treatments</title>
		<link>https://bioengineer.org/progress-in-collagen-disorder-research-and-treatments/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Thu, 13 Nov 2025 01:25:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Collagen disorders]]></category>
		<category><![CDATA[Collagen research advancements]]></category>
		<category><![CDATA[CRISPR-Cas9]]></category>
		<category><![CDATA[Gene Therapy]]></category>
		<category><![CDATA[Genetic disorder treatments]]></category>
		<guid isPermaLink="false">https://bioengineer.org/progress-in-collagen-disorder-research-and-treatments/</guid>

					<description><![CDATA[In recent years, the scientific community has made significant strides in the understanding and treatment of collagen disorders, a diverse group of genetic conditions that arise from defects in collagen synthesis. Collagen, a primary structural protein in the human body, plays a crucial role in the integrity and function of various tissues, including skin, bones, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">295857</post-id>	</item>
	</channel>
</rss>
